News

NBDF Statement on Passage of HR 1 – “One Big Beautiful Bill Act”

Advocacy & Legislation, Health and Well Being, Industry News & Research

This week, Congress passed a bill, the “One Big Beautiful Bill Act,” that will have widespread impacts on the bleeding disorders community…

Read More

Pfizer Announces Phase 3 Trial Results for Hemophilia/Inhibitor Therapy

Industry News & Research

HYMPAVZI™ (marstacimab-hncq) is FDA-approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric individuals 12…

Read More

NFRC Features Resources Supporting Joint Heath in People with Bleeding Disorders

Advocacy & Legislation, Health and Well Being, Living with a Bleeding Disorder

Discover Resources on Bleeding Disorders and Joint Health Summer is now in full swing, with the sunny promise of more opportunities to…

Read More

Literature Review Reaffirms Clinical Relevance of Von Willebrand Disease Guideline

Industry News & Research

A comprehensive literature review was conducted to ensure that the von Willebrand disease guidelines were still clinically appropriate and informed by the…

Read More

National Research Blueprint Becomes Bleeding Disorders Research Collaborative

Industry News & Research

New name reflects community leadership and a shift from planning to action. The National Bleeding Disorders Foundation’s (NBDF) National Research Blueprint (NRB), launched…

Read More

Be Biopharma Announces First Hemophilia Patient Dosed with New Cell Therapy

Industry News & Research

BE-101 is engineered to insert the human factor IX (FIX) gene into primary human B cells and initiate the continuous production of…

Read More

Beware Healthcare

Health and Well Being, Industry News & Research, Living with a Bleeding Disorder

The Coalition for Hemophilia B has summarized threats to healthcare from the current administration. What’s at risk? Currently, more than 24 million…

Read More

Prophy Treatment Research is Promising

Living with a Bleeding Disorder

Roche announced positive data from its Phase I/II NXTAGE trial of NXT007, a next-generation investigational therapy intended as a prophylactic treatment option…

Read More

PBM Podcast

Health and Well Being, Living with a Bleeding Disorder

Listen to a podcast on the power of PBM — pharmacy benefit managers. First exposed in LA Kelley Communications’ issue of PEN…

Read More

HemoLife Podcast

Health and Well Being, Living with a Bleeding Disorder

This podcast, hosted by L.A. Aguayo, a man with hemophilia who is an elite body builder, encourages conversations among members of the…

Read More

GLHF’s Bleeding Disorders Conference Offered a Weekend of Connection and Community

GLHF News, Living with a Bleeding Disorder

Earlier this summer, families from across Wisconsin gathered at the Kalahari Resort in Wisconsin Dells for GLHF’s annual Wisconsin Bleeding Disorders Conference….

Read More

Camp Klotty Pine Counselor Spotlight – Meet Julia and Maria

GLHF News

Meet Julia Hometown: Janesville, WI How many summers have you been coming to Camp? This will be my 9th summer! What’s your…

Read More

What’s Next in Bleeding Disorders Care?

Health and Well Being, Industry News & Research, Living with a Bleeding Disorder

The National Bleeding Disorders Foundation’s 77th annual Bleeding Disorders Conference will take place from August 21-23, 2025. We hope you join us…

Read More

Get Ready for Camp Klotty Pine – August 3-8!

GLHF News

The countdown has begun, and the camp experience truly starts before campers even steps onto the bus. Preparing together can help your…

Read More

Congress Needs to Hear from You!

Advocacy & Legislation, Health and Well Being, Industry News & Research, Living with a Bleeding Disorder

In conjunction with NBDF and other national partners, GLHF encourages you to take action now. Right now, US Senators are debating a…

Read More

Breaking Barriers in Bleeding & Thrombotic Disorders in Women

Living with a Bleeding Disorder, Women with Bleeding Disorders

The 2025 Research Journal Club brings together experienced researchers, new research fellows, and lived experience experts to explore critical topics in bleeding…

Read More

Factor X Deficiency: Understanding This Rare Bleeding Disorder

Health and Well Being, Industry News & Research, Living with a Bleeding Disorder

Check out this guide to why the condition occurs, how to recognize symptoms, and what you can do to manage it.

Read More

What’s Hurting Your Mental Health and What You Can Do About It

Health and Well Being, Living with a Bleeding Disorder

These five factors can negatively affect you, especially if you have a chronic health condition.

Read More

NEJM Publishes Follow-up Data on Hemophilia B Gene Therapy Product

Gene Therapy, Industry News & Research

The New England Journal of Medicine (NEJM) recently published long-term follow up data on patients who have previously received the hemophilia B gene…

Read More

New Paper Features Hemophilia Gene Editing Lexicon

Gene Therapy, Industry News & Research

NBDF, ASGCT, and ISTH publish a new paper offering a standardized lexicon to guide communication on gene editing in hemophilia research and…

Read More

Wisconsin All Copays Count Coalition Urges Action on Cole’s Act

Advocacy & Legislation, Living with a Bleeding Disorder

Oregon, North Dakota, Indiana, and Vermont join 19 other states that have passed copay accumulator bans. As the national momentum to protect…

Read More

From Intern to Board President – Dave Amoroso Shares His Experience and Perspective

Advocacy & Legislation, GLHF News

by: Danielle Lennie Dave Amoroso took an internship position at Great Lakes Hemophilia Foundation (GLHF) in 1985 while attending Marquette University. “I…

Read More

Get with the Beats!

Health and Well Being, Living with a Bleeding Disorder

2025 Beats Music Application – Nashville, TN (July 16, 2025 – July 20, 2025) – Apply by June 4. Travel scholarships available!…

Read More

Legislative Update: AB173, SB203, Cole’s Act, Copay Accumulator Adjusters, PBMs

Advocacy & Legislation, GLHF News

The average annual cost of clotting factor therapies for a person with severe hemophilia is roughly $300,000. For patients with inhibitors, expenses…

Read More